rs751006503
Variant summary
Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_016239.4(MYO15A):c.9025C>T(p.Pro3009Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000105 in 1,614,186 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Synonymous variant affecting the same amino acid position (i.e. P3009P) has been classified as Likely benign.
Frequency
Consequence
NM_016239.4 missense
Scores
Clinical Significance
Conservation
Publications
- autosomal recessive nonsyndromic hearing loss 3Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), PanelApp Australia
- nonsyndromic genetic hearing lossInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- hearing loss, autosomal recessiveInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 0 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| MYO15A | NM_016239.4 | c.9025C>T | p.Pro3009Ser | missense_variant | Exon 52 of 66 | ENST00000647165.2 | NP_057323.3 | |
| MYO15A | XM_017024715.3 | c.9028C>T | p.Pro3010Ser | missense_variant | Exon 50 of 64 | XP_016880204.1 | ||
| MYO15A | XM_017024714.3 | c.8965C>T | p.Pro2989Ser | missense_variant | Exon 49 of 63 | XP_016880203.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| MYO15A | ENST00000647165.2 | c.9025C>T | p.Pro3009Ser | missense_variant | Exon 52 of 66 | NM_016239.4 | ENSP00000495481.1 |
Frequencies
GnomAD3 genomes AF: 0.0000394 AC: 6AN: 152214Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.00000802 AC: 2AN: 249500 AF XY: 0.00000739 show subpopulations
GnomAD4 exome AF: 0.00000752 AC: 11AN: 1461854Hom.: 0 Cov.: 32 AF XY: 0.00000688 AC XY: 5AN XY: 727238 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000394 AC: 6AN: 152332Hom.: 0 Cov.: 32 AF XY: 0.0000403 AC XY: 3AN XY: 74492 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not specified Uncertain:1
Variant classified as Uncertain Significance - Favor Benign. The p.Pro3009Ser va riant in MYO15A has not been previously reported in individuals with hearing los s, but has been identified in 1/11572 Latino chromosomes by the Exome Aggregatio n Consortium (ExAC, http://exac.broadinstitute.org). Although this variant has b een seen in the general population, its frequency is not high enough to rule out a pathogenic role. The proline (Pro) at position 3009 is not conserved in mamma ls or evolutionarily distant species with 2 mammals (prairie vole and guinea pig ) having a serine (Ser) at this position, suggesting that the variant may be tol erated. Additional computational prediction tools do not provide strong support for or against an impact to the protein. In summary, the clinical significance o f this variant cannot be determined with certainty; however, the conservation da ta suggests that it is more likely to be benign. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at